Quality of life decrements in men with prostate cancer undergoing androgen deprivation therapy
Author:
Affiliation:
1. Department of Medicine; The University of Melbourne; Heidelberg Vic. Australia
2. Department of Endocrinology; Austin Health; Heidelberg Vic. Australia
3. Department of Radiation Oncology; Austin Health; Heidelberg Vic. Australia
Funder
National Health and Medical Research Council
Publisher
Wiley
Subject
Endocrinology, Diabetes and Metabolism,Endocrinology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/cen.13249/fullpdf
Reference32 articles.
1. National practice patterns and time trends in androgen ablation for localized prostate cancer;Cooperberg;Journal of the National Cancer Institute,2003
2. Adverse effects of androgen deprivation therapy and strategies to mitigate them;Nguyen;European Urology,2015
3. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer;Lubeck;Urology,2001
4. Health related quality of life for men treated for localized prostate cancer with long-term followup;Huang;Journal of Urology,2010
5. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry;Punnen;European Urology,2015
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hormone Deprivation–Free Survival—Inequities Persist in Research Priorities for Patients With Cancer;JAMA Oncology;2024-07-25
2. Helpful tool or blunt instrument?—the European Association of Urology Biochemical Recurrence Risk Classification as a decision-making tool for salvage radiotherapy;Translational Andrology and Urology;2024-05
3. Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation;Trials;2024-04-12
4. Changes in Quality of Life and Sexual Function After Luteinizing Hormone‐Releasing Hormone (LHRH) Agonists and Orchiectomy in Men With Metastatic Prostate Cancer: Results From a Randomized Trial;Cureus;2024-03-11
5. A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating “BRCAness” Genotype (ROAR);The Oncologist;2024-03-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3